Search results
Eli Lilly's Alzheimer's Drug Gains Unanimous FDA Panel Backing
Verywell Health via Yahoo News· 6 days agoAn FDA advisory panel endorsed donanemab, Eli Lilly’s monoclonal antibody drug designed to slow the...
New Alzheimer's drug brings hope to those dealing with the disease
NewsWest 9· 19 hours agoOnce news of the FDA Advisory Council’s recent unanimous endorsement of the drug donanemab reached...
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 6 days agoCredit - Fotografixx—Getty Images After many years of slow progress, drug companies searching for...
Alzheimer's could be treated by "rejuvenating" transplant
Newsweek· 5 days agoBone marrow transplants from young donors could potentially slow the development of Alzheimer's ...
Few UK people likely to be suitable for new Alzheimer's drugs when they become available
Medical Xpress· 6 days agoFew people in the UK with early stage Alzheimer's disease are likely to be suitable for the latest...
Experimental Alzheimer’s drug gets FDA advisory panel's thumbs-up: ‘Progress is happening’
AOL· 6 days agoAn experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration (FDA) advisory panel on Monday. Donanemab is designed to treat symptoms of ...
Silver Alert issued for man with Alzheimer’s disease who went missing in Madison
WKRN Nashville· 2 days agoBoth the Metro Nashville Police Department (MNPD) and the Tennessee Bureau of Investigation (TBI)...
Independent FDA Panel Endorses New Alzheimer’s Disease Treatment
WebMD· 7 days agoThe treatment can cause brain swelling or brain bleeding. Ultimately, advisors agreed that donanemab is safe and that the treatment’s benefits outweigh the risks. If fully approved, donanemab ...
Medicare patients unable to get Alzheimer's drug sparks backlash
Newsweek· 7 hours agoAlzheimer's is an incurable disease that affects roughly 6.7 million Americans. In recent years,...
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
Barrons.com· 6 days agoSTOCK ALERT A new Eli Lilly treatment for Alzheimer’s disease appears set to nab Food and Drug...